Xueyi Liang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

E2F3 activates NF-κB signaling through TRIM26 mediated TAB1 ubiquitination in pancreatic cancer.

E2F3 activates NF-κB signaling through TRIM26 mediated TAB1 ubiquitination in pancreatic cancer.

Journal: International journal of biological sciences

Published: November 02, 2025

CK2-mediated HDAC5 shuttling regulates DNA end resection through Ku70 deacetylation.

CK2-mediated HDAC5 shuttling regulates DNA end resection through Ku70 deacetylation.

Journal: Theranostics

Published: August 02, 2025

HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis.

HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis.

Journal: The Journal of clinical investigation

Published: May 20, 2025

BAP1 Represses Sequential Activation of IRAKs and NF-κB Signaling in Pancreatic Cancer.

BAP1 Represses Sequential Activation of IRAKs and NF-κB Signaling in Pancreatic Cancer.

Journal: International journal of biological sciences

Published: October 10, 2024

HDAC5 depletion promotes hyper-acetylation of FOXA1 and potentiates HIF1α transcriptional activation in pancreatic cancer.

HDAC5 depletion promotes hyper-acetylation of FOXA1 and potentiates HIF1α transcriptional activation in pancreatic cancer.

Journal: Molecular cell

Published: April 25, 2024

BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer.

BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 04, 2024

Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.

Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 30, 2023

Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.

Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.

Journal: International immunopharmacology

Published: June 25, 2023

USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2.

USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 07, 2023

Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression.

Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression.

Journal: Cells

Published: September 01, 2022

Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosomal miRNA-21 Expression.

Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosomal miRNA-21 Expression.

Journal: Oxidative medicine and cellular longevity

Published: July 08, 2022

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.

Journal: Theranostics

Published: November 25, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026